Gevo, Inc. Faces Delisting Concerns

TL;DR

GEVO might get delisted, check their listing status ASAP.

AI Summary

Gevo, Inc. filed an 8-K on August 28, 2024, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The company is based in Englewood, Colorado, and its principal executive offices are located at 345 Inverness Drive South, Building C, Suite 310.

Why It Matters

This filing indicates potential issues with Gevo's continued listing on a stock exchange, which could impact its stock price and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and overall financial stability.

Key Players & Entities

• Gevo, Inc. (company) — Registrant
• August 28, 2024 (date) — Date of earliest event reported
• Englewood, CO (location) — City and State of principal executive offices
• 345 Inverness Drive South, Building C, Suite 310 (address) — Address of principal executive offices

FAQ

Key Financial Figures

• $0.01 — ch registered Common Stock, par value $0.01 per share GEVO Nasdaq Capital Mark
• $1.00 — 24, 2025, to regain compliance with the $1.00 per share minimum bid price requirement

Filing Documents

• tm2422976d1_8k.htm (8-K) — 25KB
• 0001104659-24-094614.txt ( ) — 196KB
• gevo-20240828.xsd (EX-101.SCH) — 3KB
• gevo-20240828_lab.xml (EX-101.LAB) — 33KB
• gevo-20240828_pre.xml (EX-101.PRE) — 22KB
• tm2422976d1_8k_htm.xml (XML) — 4KB

01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 28, 2024, Gevo, Inc. (the "Company") received a letter from the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") granting the Company an additional 180 calendar days, or until February 24, 2025, to regain compliance with the $1.00 per share minimum bid price requirement required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Marketplace Rule 5550(a)(2) (the "Minimum Bid Price Rule"). As previously reported, on February 29, 2024, the Company received a notification letter from the Staff advising the Company that for 30 consecutive trading days preceding the date of the notice from Nasdaq, the bid price of the Company's common stock had closed below the $1.00 per share minimum required for continued listing on the Nasdaq Capital Market pursuant to the Minimum Bid Price Rule. The Company was provided an initial 180 calendar days, or until August 27, 2024, to regain compliance with the Minimum Bid Price Rule. The Nasdaq determination to grant the second compliance period was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the bid price requirement, and the Company's written notice of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. To regain compliance, the bid price of the Company's common stock must close at or above $1.00 per share for a minimum of ten consecutive business days at any time during the second 180-day compliance period. The Company intends to monitor the closing bid price of its common stock and may, if appropriate, consider implementing available options, including submitting a reverse stock split for approval by the Company's sto

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GEVO, INC. Dated: August 29, 2024 By: / s/ E. Cabell Massey E. Cabell Massey Vice President, Legal and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR